Home   About this service   Get the news  
+32 2 743 34 03

UCB [BE0003739530 / UCB]

UCB Media Room: Disposals of own shares


[13/08/2021 | 20:07]

** Disposals of own shares

Brussels (Belgium), 13 August 2021 =E2=80=93 20:00 (CEST) =E2=80=93 regulat=
ed information

Disposal of own shares

In accordance with article 8:6 of the Royal Decree executing the Belgian Co=
de of Companies and Associations, UCB=C2=A0announces that, following exerci=
ses of stock options by members of its personnel, it has disposed of UCB sh=
ares OTC in view of deliveries of these shares to the relevant members of t=
he personnel, within the framework of the Long Term Incentive Program of th=
e UCB Group, as follows:


This press release is available on UCB=C2=A0SA/NV=E2=80=99s website via the=
following link. (https://www.ucb.com/stories-media/Press-Releases)
Investor Relations
Antje Witte
Investor Relations, UCB
T +32 2 559 94 14
antje.witte@ucb.com (mailto:antje.witte@ucb.com)

Corporate Communications
Laurent Schots
Media Relations, UCB
laurent.schots@ucb.com (mailto:laurent.schots@ucb.com)

About UCB
UCB, Brussels, Belgium (www.ucb.com (http://www.ucb.com/) ) is a global bio=
pharmaceutical company focused on the discovery and development of innovati=
ve medicines and solutions to transform the lives of people living with sev=
ere diseases of the immune system or of the central nervous system. With ap=
proximately 8 400 people in nearly 40 countries, the company generated reve=
nue of =E2=82=AC 5.3 billion in 2020. UCB is listed on Euronext Brussels (s=
ymbol: UCB). Follow us on Twitter: @UCB_news

Image (https://mb.cision.com/Public/18595/3396157/bb08e28cbaede785_org.png)
Disposals of own shares (https://mb.cision.com/Public/18595/3396157/9a14db7=
7267dc407.pdf) GenericFile
210813 - Vervreemding van eigen aandelen NED (https://mb.cision.com/Public/=
18595/3396157/9a14db77267dc407.pdf) GenericFile
210813 - Alie nation d actions propres FR (https://mb.cision.com/Public/185=
95/3396157/8ca4c64f0dd412d6.pdf) GenericFile
210813 - Disposals of own shares ENG (https://mb.cision.com/Public/18595/33=

If you would rather not receive future communications from UCB SA, please g=
o to https://eu.vocuspr.com/OptOut.aspx?2973226x20421x79464x1x6868579x24000=
UCB SA, All=C3=A9e de la Recherche, 60 ., Brussels, . B - 1070 Belgium